People Matter
Pendulum Therapeutics
Pendulum Therapeutics
pendulum.co

Locations

San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series C+

founded in

2012

Pendulum Therapeutics believes therapies developed using evidence-based microbiome science and DNA sequencing can help heal the body from within. Armed with 13 patents and 42 pending, the company introduced its flagship product Pendulum Glucose Control, a medical probiotic, in 2020 and demonstrated its efficacy in lowering blood sugar spikes and reducing A1C in a published clinical trial. Founded in 2013 by a diverse team of scientists with deep microbiology, biochemistry, computational, and clinical expertise, Pendulum has raised $111 million to date from Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, AME Cloud Ventures and Mayo Clinic among others. Pendulum Therapeutics is headquartered in San Francisco.

Something looks off?
Open jobs at Pendulum Therapeutics

On-site & Remote